4.7 Article

Increased Expression of TSH Receptor by Fibrocytes in Thyroid-Associated Ophthalmopathy Leads to Chemokine Production

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 97, Issue 5, Pages E740-E746

Publisher

ENDOCRINE SOC
DOI: 10.1210/jc.2011-2514

Keywords

-

Funding

  1. National Institutes of Health [EY008976, EY011708, DK063121, EY016339, RR00425, EY021197]
  2. Research to Prevent Blindness
  3. Bell Charitable Foundation
  4. Howard Hughes Medical Institute

Ask authors/readers for more resources

Context: The molecular basis for anatomically dispersed clinical manifestations in Graves' disease (GD) eludes our understanding. Bone marrow-derived, pluripotent fibrocytes represent a subset of peripheral blood mononuclear cells and infiltrate the orbital and thyroid tissues in GD. These cells may be involved in the pathogenesis of thyroid-associated ophthalmopathy (TAO). Objective: The objective of the study was to quantify fibrocyte display of functional cell surface TSH receptor (TSHR), identify the profile of chemokines they express after TSHR activation, and determine whether circulating TSHR+ peripheral blood fibrocytes are more frequent in situ in patients with TAO. Design/Setting/Participants: Using a newly developed technique, fibrocytes were directly identified in peripheral blood from 31 patients with TAO and 19 healthy subjects receiving care at a multidisciplinary academic center. Main Outcome Measures: The frequency in situ of fibrocytes (collagen 1(+), CD45(+), CD34(+), CD14(+), CD86(+) peripheral blood mononuclear cells) was assessed by multiparameter flow cytometry and correlated to clinical disease activity and smoking status. Levels of TSHR-displaying fibrocytes and their response to TSH and TSHR-activating antibody, M22, were measured by flow cytometry, Luminex, and real-time PCR. Results: The levels of TSHR expression by fibrocytes are substantially higher than those found in orbital fibroblasts. Moreover, the frequency of TSHR+ fibrocytes in patients with TAO was greater than that in healthy subjects in situ. Their abundance is not influenced by disease activity or smoking history. These cells produce high levels of several cytokines and chemokines including IL-8, regulated upon activation, normal T cell expressed and secreted, and monocyte chemoattractant protein-1 when treated with TSH or M22. TSH induces IL-8 production at the pretranslational level. This induced cytokine can be detected in intact fibrocytes ex vivo. Conclusions: Frequency of circulating TSHR+ fibrocytes is markedly increased in patients with TAO, and they express proinflammatory chemokines in response to TSH. Because they infiltrate both orbit and thyroid in GD, they may represent the link between systemic immunoreactivity and organ-specific autoimmunity. (J Clin Endocrinol Metab 97: E740-E746, 2012)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes: Potential Relevance to Thyroid-Associated Ophthalmopathy

Roshini Fernando, Terry J. Smith

Summary: The study compared the expression of various genes and molecules in fibrocytes and orbital fibroblasts (GD-OF) in thyroid-associated ophthalmopathy. The results showed significant differences in hyaluronan synthesis, interleukin-6, and tumor necrosis factor-alpha production between fibrocytes and GD-OF, which were partly regulated by Slit2. These findings provide insights into the disease pathogenesis.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Cell Biology

Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy

Joseph A. M. J. L. Janssen, Terry J. Smith

Summary: The insulin-like growth factor-I receptor (IGF-IR) plays an important role in the pathogenesis of TAO, and targeting this receptor with specific biologic agents may lead to a paradigm shift in the therapy of TAO.

CELLS (2021)

Article Ophthalmology

A randomized comparative study of inferomedial vs. balanced orbital decompression. Analysis of changes in orbital volume, eyelid parameters, and eyeball position

Thais de Sousa Pereira, Cristiane de Almeida Leite, Cristina Hiromi Kuniyoshi, Eloisa M. M. S. Gebrim, Mario L. R. Monteiro, Allan C. Pieroni Goncalves

Summary: Both inferomedial and balanced orbital decompression can successfully expand orbit capacity, but balanced orbital decompression is more efficient at reducing exophthalmos, probably due to the inclusion of the lateral wall. Upper and lower eyelid retraction improved after surgery, but only lower eyelid elevation was correlated with exophthalmos reduction.
Review Endocrinology & Metabolism

2021 update on thyroid-associated ophthalmopathy

E. J. Neag, T. J. Smith

Summary: Significant scientific advances have been made in the field of TAO over the past decade, including a deeper understanding of autoimmune diseases and TAO, as well as the development of new medical treatment methods. Future research will continue to build on these advances, further accelerating the pace of scientific discovery.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Editorial Material Oncology

Are 5-Year Randomized Clinical Trial Results Sufficient for Implementation of Short-Course Whole Breast Radiation Therapy?

Erin F. Gillespie, Atif J. Khan, Oren Cahlon, Lior Z. Braunstein

PRACTICAL RADIATION ONCOLOGY (2021)

Letter Endocrinology & Metabolism

Comment on the 2021 EUGOGO Clinical Practice Guidelines for the Medical Management of Graves' Orbitopathy

Terry J. Smith

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)

Article Multidisciplinary Sciences

Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy

Roshini Fernando, Oshadi Caldera, Terry J. Smith

Summary: Thyroid-associated ophthalmopathy (TAO) is a disfiguring and potentially blinding autoimmune component of Graves' disease, driven by autoantibodies targeting the TSHR/IGF-IR complex. Teprotumumab, an anti-IGF-IR inhibitor, attenuates expressions of MHC II and B7 proteins in CD34(+) fibrocytes, potentially by reducing gene transcriptional activity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Endocrinology & Metabolism

It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease

Leonard Girnita, Terry J. Smith, Joseph A. M. J. L. Janssen

Summary: This article reviews the generation of autoantibodies in thyroid eye disease (TED) and their direct effects on orbital fibroblast responses through the TSH receptor (TSHR), IGF-I receptor (IGF-IR), or both. Evidence suggests that IGF-IR functions not only as a typical tyrosine kinase receptor, but also as a functional receptor tyrosine kinase/G-protein-coupled receptor hybrid. Teprotumumab, a monoclonal IGF-IR antibody, effectively reduces TED disease activity and its in vitro actions on fibrocytes and orbital fibroblasts. The article proposes four possible IGF-IR activation models underlying the clinical responses to teprotumumab in TED patients.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Attitudes and access to resources and strategies to improve quality of radiotherapy among US radiation oncologists: A mixed methods study

Y. Helen Zhang, Elaine Cha, Kathleen Lynch, Renee Gennarelli, Jeffrey Brower, Michael Sherer, Daniel W. Golden, Susan Chimonas, Deborah Korenstein, Erin F. Gillespie

Summary: This study aimed to assess contouring-related practices among US radiation oncologists and explore the factors affecting access to and use of resources and quality improvement strategies. The results showed that contouring-related questions arise in a significant percentage of clinical cases among the respondents, and published atlases and consulting other radiation oncologists are the most frequently accessed resources. The study also identified potential opportunities to improve contour quality, such as improving access to disease-site specialists and implementing contour-specific peer review.

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2022)

Letter Endocrinology & Metabolism

Letter to the editor regarding Bartalena et al. 2022

T. J. Smith

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Letter Oncology

In Reply to Rabinovitch

Erin F. Gillespie, Atif J. Khan, Lior Z. Braunstein

PRACTICAL RADIATION ONCOLOGY (2022)

Article Endocrinology & Metabolism

Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy

Roshini Fernando, Terry J. Smith

Summary: Teprotumumab has been found to modulate the expression of inflammation-associated factors IL-6 and IL-8 in fibrocytes and orbital fibroblasts, potentially alleviating the symptoms of thyroid-associated ophthalmopathy.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease

Terry J. Smith

Summary: Thyroid eye disease (TED) is a challenging condition to treat, but recent scientific advances have provided more options. Glucocorticoid steroids are the commonly prescribed treatment, but they have limited effectiveness. Other medications such as mycophenolate, rituximab, and teprotumumab have shown some promise. Targeted therapies aimed at prostaglandin receptors, vascular endothelial growth factor, mTOR, and cholesterol pathways have also been proposed. Restoring immune tolerance may ultimately be the most effective and safe treatment for TED.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Oncology

Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality

Edward Christopher Dee, Neil K. Taunk, Fumiko L. Chino, Curtiland Deville, Shearwood McClelland, Vinayak Muralidhar, Sean N. McBride, Erin F. Gillespie, Kosj Yamoah, Paul L. Nguyen, Brandon A. Mahal, Karen M. Winkfield, Neha Vapiwala, Patricia Mae G. Santos

Summary: Shorter radiation regimens may reduce treatment noncompletion rates, but black patients are consistently less likely to receive them for breast cancer and prostate cancer. However, evidence suggests that these shorter regimens could lead to similar oncologic outcomes.

JCO ONCOLOGY PRACTICE (2023)

Article Medicine, General & Internal

Ocular motility changes after inferomedial wall and balanced medial plus lateral wall orbital decompression in Graves' orbitopathy: a randomized prospective comparative study

Cristiane de Almeida Leite, Thais de Sousa Pereira, Jeane Chiang, Rodrigo Bernal Moritz, Allan Christian Pieroni Goncalves, Mario Luiz Ribeiro Monteiro

Summary: The study compared the surgical outcomes of IM-OD and ML-OD for patients with inactive GO, finding that ML-OD resulted in greater exophthalmos reduction, while IM-OD had a lower risk of new-onset esotropia.

CLINICS (2021)

No Data Available